Table 1 Clinical characteristics of study subjects (n = 129)
Clinical characteristicsM | Mean ± SD |
|---|---|
Age (years) | 45.7 ± 10.9 |
Age of onset (years) | 24.6 ± 9.5 |
Education (years) | 11.8 ± 3.3 |
Latency to CBZ treatment (Years) | 10.8 ± 7.6 |
Follow-up period after CBZ treatment (Years) | 10.4 ± 5.2 |
Current CBZ dose (mg) | 571.3 ± 212.6 |
Current CBZ plasma level (μg/mL) | 7.8 ± 5.9 |
Mood episodes before CBZ treatment | N (%) |
1 | 42 (32.6) |
2 | 22 (17.1) |
3 | 28 (21.7) |
4 | 16 (12.4) |
≧5 | 21 (16.3) |
Mood episodes after CBZ treatment | N (%) |
0 | 63 (48.8) |
1 | 21 (16.3) |
2 | 22 (17.1) |
3 | 6 (4.7) |
≧4 | 17 (13.2) |